Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

[page_title]

ISTNET (Developmental) neurotoxicity Workshop

23 January 2014 – 24 January 2014, 09.00 – 17.00

Venue: Institute of Pharmacology and Toxicology, Universityof Zürich, Switzerland

The number of participants is restricted

Further information: istnet@uta.fi

The currently used regulatory test methods in the fields of neurotoxicity (NT) and developmental neurotoxicity (DNT) have several limitations. One of them is that the species differences between rodent and human nervous systems are pronounced, and also cellular signaling may differ considerably. Differences in signal transduction between rodents and man can change the toxicodynamic and thus the effects of compounds on organs and organisms.  Therefore, new concepts for safety testing which are based on human biology are being developed. To date, this process has been SCIENCE-driven, i.e. the direction of research and the output obtained were mainly driven by academic interest, and theoretical considerations. This approach has largely failed to deliver validated test methods. We therefore promote a NEED-driven process, i.e. focus of research activities on regulatory requirements. For this purpose, we want to bring together the regulatory experts together with test developers and potential users to start a constructive dialog on test requirements, right from the start of new developments. A first step will be a common workshop. In this meeting we will gather an expert panel including representatives of regulatory bodies and test developers from academia and industry. The regulatory experts will present the requirements for new human cell -based NT/DNT tests for risk assessment and management. This meeting will serve as an a starting point for discussion  between scientists from academia and industry and scientists from regulatory bodies to define the requirements for in vitro NT/DNT toxicity tests ready for regulatory purpose.